[HTML][HTML] Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine

MA Brockman, F Mwimanzi, Y Sang, K Ng, O Agafitei… - medRxiv, 2021 - ncbi.nlm.nih.gov
Background. Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However …

Characterization of the humoral immune response to BNT162b2 in elderly residents of long-term care facilities five to seven months after vaccination

M Delbrück, S Hoehl, T Toptan, B Schenk, K Grikscheit… - medrxiv, 2021 - medrxiv.org
The elderly residing in long-term care facilities (LTCFs) are a group at high risk for COVID-
19. Hence, monitoring of the vaccine-based immunity has a pivotal role in identifying …

Significant reduction in humoral Immunity among healthcare workers and nursing home residents 6 months AFTER COVID-19 BNT162b2 mRNA vaccination

DH Canaday, OA Oyebanji, D Keresztesy, M Payne… - MedRxiv, 2021 - medrxiv.org
High COVID-19 mortality among nursing home (NH) residents led to their prioritization for
SARS-CoV-2 vaccination; most NH residents received BNT162b2 mRNA vaccination under …

Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities

M Trigueros, E Pradenas, D Palacín… - Age and …, 2022 - academic.oup.com
Background SARS-CoV-2 vaccination is the most effective strategy to protect older residents
of long-term care facilities (LTCF) against severe COVID-19, but primary vaccine responses …

Antibody response 3 months after 2 doses of BNT162b2 mRNA COVID-19 vaccine in residents of long-term care facilities

R Causa, D Almagro-Nievas, M Rivera-Izquierdo… - Gerontology, 2022 - karger.com
Background: Older adults living in long-term care facilities (LTCFs) are at increased risk for
severe outcomes from COVID-19 and were identified as a priority group in COVID-19 …

[HTML][HTML] Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents

DH Canaday, L Carias, OA Oyebanji, D Keresztesy… - medRxiv, 2021 - ncbi.nlm.nih.gov
The SARS-CoV-2 pandemic impact on nursing home (NH) residents prompted their
prioritization for early vaccination. To fill the data gap for vaccine immunogenicity in NH …

Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers

SAA Coggins, ED Laing, CH Olsen… - Open Forum …, 2022 - academic.oup.com
Background The relationship between postvaccination symptoms and strength of antibody
responses is unclear. The goal of this study was to determine whether adverse effects …

Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune …

J Ontañón, J Blas, C de Cabo, C Santos… - …, 2021 - thelancet.com
Background SARS-CoV-2 vaccines are an invaluable resource against COVID-19. Current
vaccine shortage makes it necessary to prioritize distribution to the most appropriate …

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes

P Pannus, KY Neven, S De Craeye, L Heyndrickx… - medRxiv, 2021 - medrxiv.org
Background Residents of nursing homes (NH) are at high risk of COVID-19 related morbidity
and death and may respond poorly to vaccination because of old age and frequent …

Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers

J Oliveira-Silva, T Reis, C Lopes, R Batista-Silva… - Vaccine, 2022 - Elsevier
Abstract Background The SARS-CoV-2 pandemic was responsible for the death of millions
of people around the world, which accelerated the study of vaccines. The BNT162b2 mRNA …